EPISODE · Apr 28, 2026 · 22 MIN
Attention-Deficit/Hyperactivity Disorder Subtypes Defined by Cognition Have a Distinct Neural and Clinical Profile and Differ in Response to Atomoxetine: JAACAP May 2026
from Journal of the American Academy of Child and Adolescent Psychiatry · host American Academy of Child and Adolescent Psychiatry
May 2026: Contributing Editor Deepika Shaligram interviews John E. Leikauf on a study that identified new attention-deficit/hyperactivity disorder (ADHD) subtypes using computerized attention-based tasks and compared these new subtypes’ responses to 2 ADHD medications: methylphenidate (stimulant) and atomoxetine (nonstimulant).
Embed this episode
Ready to play
Attention-Deficit/Hyperactivity Disorder Subtypes Defined by Cognition Have a Distinct Neural and Clinical Profile and Differ in Response to Atomoxetine: JAACAP May 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.